| 1 |
30794402 | Discovering Putative Protein Targets of Small Molecules: A Study of the p53 Activator Nutlin. | 2019 Apr 22 |
1 |
| 2 |
31036564 | The histone demethylase JMJD2B is critical for p53-mediated autophagy and survival in Nutlin-treated cancer cells. | 2019 Jun 7 |
1 |
| 3 |
26959882 | P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis. | 2016 May 31 |
1 |
| 4 |
26046940 | Elucidation of Ligand-Dependent Modulation of Disorder-Order Transitions in the Oncoprotein MDM2. | 2015 Jun |
2 |
| 5 |
22872685 | Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells. | 2012 Oct 11 |
1 |
| 6 |
20371712 | Nutlin-3a induces cytoskeletal rearrangement and inhibits the migration and invasion capacity of p53 wild-type cancer cells. | 2010 Apr |
1 |
| 7 |
20850924 | MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma. | 2010 Dec 28 |
1 |